Product Description
With revenues from the top five therapeutic antibodies accounting for a majority of the recent pharmaceutical sales, the research and development in the field has exploded over the past several years and is expected to grow with new emerging monoclonal antibodies like Numax, Lucentis, Actemra, and others. In Therapeutic Antibodies: Methods and Protocols, leading experts from academic laboratories and biotechnology companies present an extensive set of protocols for the discovery and development of therapeutic antibodies, featuring sections devoted to recombinant antigens, antibody libraries, antibody discovery, antibody engineering, and antibody preclinical development. Written in the highly successful Methods in Molecular Biology™ series format, the chapters contain brief introductions to their respective subjects, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes highlighting tips on troubleshooting and avoiding known pitfalls. Comprehensive and cutting-edge, Therapeutic Antibodies: Methods and Protocols serves as a key resource for researchers and antibody engineers investigating and participating in this rapidly growing therapeutic market segment.

SIMILAR PRODUCTS

	Therapeutic Monoclonal Antibodies: From Bench to Clinic by Zhiqiang An (Editor) 70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Most chapters contain experimental data to illustrate the principles described in them. Authors provide detailed methodologies that readers can take away...
	Antibody Engineering: Methods and Protocols (Methods in Molecular Biology) by Benny K. C. Lo (Editor) Univ. of Cambridge, UK. Presents cutting-edge techniques for the generation and optimization of recombinant antibodies for offers protocols for affinity maturation and reducing immunogenicity of antibodies. Discusses the novel applications of antigen-binding affinity and specificity. DNLM: Antibodies--therapeutic use--Laboratory Manuals.
	Making and Using Antibodies: A Practical Handbook by Gary C. Howard (Editor), Matthew R. Kaser (Editor) Antibodies are an indispensable tool in the study of biology and medicine. Making and Using Antibodies: A Practical Handbook presents techniques in a single, comprehensive source for the production and use of antibodies. It enables researchers to immediately access lab-tested, proven protocols. Written and edited by an elite team of scientists, who have developed and refined many of the methods, this book covers- Commercially available adjuvants designed for the production of...
	Handbook of Therapeutic Antibodies 3-Volume Set by Stefan D?bel (Editor) In this most comprehensive reference source for the development, production and therapeutic application of antibodies, Volume I contains general chapters presenting established technologies and clinical applications. Volume II provides a look at emerging technologies, new therapeutic concepts, and clinical studies. The third volume features detailed and specific information about each currently approved type of antibody, including the clinical data. A must-have resource for academic...
	Current Trends in Monoclonal Antibody Development and Manufacturing (Biotechnology: Pharmaceutical Aspects) by Steven J. Shire (Editor), Wayne Gombotz (Editor), Karoline Bechtold-Peters (Editor), James Andya (Editor) Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies...